4//SEC Filing
Repella Robert 4
Accession 0001209191-13-009931
CIK 0001347178other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:40 PM ET
Size
7.4 KB
Accession
0001209191-13-009931
Insider Transaction Report
Form 4
Repella Robert
SVP & Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2013-02-14−15,000→ 45,000 total→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2013-02-14+15,000→ 15,000 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units vest in four equal annual installments beginning January 1, 2013, provided that Mr. Repella has remained in continuous service with the Issuer on each applicable vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
- [F3]Not applicable.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001532513
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:40 PM ET
- Size
- 7.4 KB